Capstone Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $2.47M | Sell |
20,292
-840
| -4% | -$102K | 0.07% | 338 |
|
|
2017
Q1 | $2.56M | Sell |
21,132
-620
| -3% | -$75.2K | 0.07% | 329 |
|
|
2016
Q4 | $2.66M | Sell |
21,752
-2,948
| -12% | -$361K | 0.08% | 307 |
|
|
2016
Q3 | $3.03M | Buy |
24,700
+127
| +0.5% | +$15.6K | 0.09% | 279 |
|
|
2016
Q2 | $2.87M | Buy |
24,573
+1,095
| +5% | +$128K | 0.09% | 277 |
|
|
2016
Q1 | $3.27M | Buy |
23,478
+1,218
| +5% | +$170K | 0.09% | 268 |
|
|
2015
Q4 | $4.25M | Buy |
22,260
+954
| +4% | +$182K | 0.12% | 207 |
|
|
2015
Q3 | $3.33M | Buy |
21,306
+1,347
| +7% | +$211K | 0.1% | 251 |
|
|
2015
Q2 | $3.61M | Buy |
19,959
+413
| +2% | +$74.7K | 0.1% | 249 |
|
|
2015
Q1 | $3.39M | Buy |
19,546
+447
| +2% | +$77.5K | 0.1% | 259 |
|
|
2014
Q4 | $3.53M | Buy |
19,099
+4,725
| +33% | +$874K | 0.1% | 251 |
|
|
2014
Q3 | $2.38M | Buy |
14,374
+305
| +2% | +$50.6K | 0.08% | 289 |
|
|
2014
Q2 | $2.2M | Sell |
14,069
-2,672
| -16% | -$417K | 0.07% | 317 |
|
|
2014
Q1 | $2.55M | Sell |
16,741
-2,318
| -12% | -$353K | 0.08% | 301 |
|
|
2013
Q4 | $2.53M | Sell |
19,059
-12,276
| -39% | -$1.63M | 0.07% | 309 |
|
|
2013
Q3 | $3.64M | Buy |
31,335
+270
| +0.9% | +$31.4K | 0.09% | 255 |
|
|
2013
Q2 | $2.87M | Buy |
+31,065
| New | +$2.87M | 0.08% | 299 |
|